• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC SOFTPAC REFOBACIN REVISION 40; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC SOFTPAC REFOBACIN REVISION 40; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Improper Chemical Reaction (2952)
Patient Problem No Information (3190)
Event Date 11/30/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Report source- foreign.The event occurred in (b)(6).The product within this report is a combination product.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Product remains implanted.
 
Event Description
It was reported the cement hardening took 20 min instead of 12 minutes.No further information has been made available at this ttime.
 
Manufacturer Narrative
(b)(4).This follow-up report is being filled to relay additional information, which was unknown at the time of the initial medwatch.The following sections were updated.Reserve sample from the same lot was evaluated and the reported event was confirmed.Testing was performed under standardized conditions and the sample tested showed the setting time was too long.Device history record (dhr) was reviewed and no discrepancies were found.Root cause was unable to be determined at this time; further investigation has been initiated to address reported issue.A summary of the investigation has been sent to the complainant.According to the available data, a non-conformity has been detected.Related to the issue, a field action was initiated, in order to recall all affected products, which is not affecting american products.To date no adverse health outcome has been reported.If any further information is found which would changer any conclusions or information, a supplemental will be filled accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC SOFTPAC REFOBACIN REVISION 40
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
helene bataille
plateau de lautagne bp75
valence cedex, IN 26903
5745273773
MDR Report Key7152598
MDR Text Key96124348
Report Number3006946279-2017-00302
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
PK150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 03/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model NumberN/A
Device Catalogue Number4730501163-1
Device Lot NumberA705B05130
Other Device ID Number(01)03599870110362
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/30/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
-
-